[1]
S. A. Kucera, PhD, M. S. Zamloot, BS ChE, M. M. Crowley, PhD, L. H. Burns, PhD, N. Friedmann, PhD, MD, and R. Barbier, MBA, “Abuse-deterrent properties of REMOXY® ER, a high-viscosity extended-release oxycodone formulation”, J of Opioid Management, vol. 14, no. 6, pp. 429–436, Nov. 2018.